Envista Holdings Corporation (NYSE:NVST – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 8,087,163 shares, a drop of 23.3% from the January 15th total of 10,544,812 shares. Based on an average daily trading volume, of 2,580,648 shares, the days-to-cover ratio is presently 3.1 days. Currently, 5.0% of the shares of the company are short sold. Currently, 5.0% of the shares of the company are short sold. Based on an average daily trading volume, of 2,580,648 shares, the days-to-cover ratio is presently 3.1 days.
Envista Price Performance
Shares of NYSE:NVST traded up $0.22 during mid-day trading on Monday, reaching $28.99. The stock had a trading volume of 2,193,354 shares, compared to its average volume of 3,587,896. The business’s 50 day moving average price is $23.89 and its 200 day moving average price is $21.63. Envista has a 1 year low of $14.22 and a 1 year high of $30.42. The company has a market cap of $4.75 billion, a P/E ratio of 103.52, a price-to-earnings-growth ratio of 1.98 and a beta of 1.01. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47.
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company’s quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts expect that Envista will post 1 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on NVST
Insider Buying and Selling at Envista
In related news, SVP Mischa Reis sold 9,675 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the transaction, the senior vice president directly owned 32,382 shares in the company, valued at approximately $971,460. The trade was a 23.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.66% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Farther Finance Advisors LLC raised its position in Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after purchasing an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd increased its position in shares of Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the last quarter. Allworth Financial LP increased its position in shares of Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares during the last quarter. UMB Bank n.a. lifted its position in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares during the last quarter. Finally, IFP Advisors Inc boosted its stake in Envista by 102.9% during the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares during the period.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Articles
- Five stocks we like better than Envista
- Think You Missed Silver? You’re Wrong. Here’s Why.
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- Silver records prices are great. Monthly income is better
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
